Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer

被引:0
|
作者
Norie Abe
Hirofumi Matsumoto
Reika Takamatsu
Kentaro Tamaki
Naoko Takigami
Kano Uehara
Yoshihiko Kamada
Nobumitsu Tamaki
Tokiwa Motonari
Mikiko Unesoko
Norihiro Nakada
Hisamitsu Zaha
Naoki Yoshimi
机构
[1] Nakagami Hospital,Department of Breast Surgery
[2] University of the Ryukyus,Department of Pathology and Oncology, Graduate School of Medicine
[3] Ryukyu University Hospital,Department of Pathology
[4] Nahanishi Clinic,Department of Breast Surgical Oncology
[5] Nakagami Hospital,Department of Pathology
来源
Virchows Archiv | 2020年 / 476卷
关键词
Tumor-infiltrating lymphocyte (TIL); Image analysis; HER2; Pathological complete response (pCR);
D O I
暂无
中图分类号
学科分类号
摘要
As visual quantification of the density of tumor-infiltrating lymphocytes (TILs) lacks in precision, digital image analysis (DIA) approach has been applied in order to improve. In several studies, TIL density has been examined on hematoxylin and eosin (HE)-stained sections using DIA. The aim of the present study was to quantify TIL density on HE sections of core needle biopsies using DIA and investigate its association with clinicopathological parameters and pathological response to neoadjuvant chemotherapy in human epidermal growth factor receptor 2 (HER2)-positive breast cancer. The study cohort comprised of patients with HER2-positive breast cancer, all treated with neoadjuvant anti-HER2 therapy. DIA software applying machine learning-based classification of epithelial and stromal elements was used to count TILs. TIL density was determined as the number of TILs per square millimeter of stromal tissue. Median TIL density was 1287/mm2 (range, 123–8101/mm2). A high TIL density was associated with higher histological grade (P = 0.02), estrogen receptor negativity (P = 0.036), and pathological complete response (pCR) (P < 0.0001). In analyses using receiver operating characteristic curves, a threshold TIL density of 2420/mm2 best discriminated pCR from non-pCR. In multivariate analysis, high TIL density (> 2420/mm2) was significantly associated with pCR (P < 0.0001). Our results indicate that DIA can assess TIL density quantitatively, machine learning-based classification algorithm allowing determination of TIL density as the number of TILs per unit area, and TIL density established by this method appears to be an independent predictor of pCR in HER2-positive breast cancer.
引用
收藏
页码:701 / 709
页数:8
相关论文
共 50 条
  • [1] Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer
    Abe, Norie
    Matsumoto, Hirofumi
    Takamatsu, Reika
    Tamaki, Kentaro
    Takigami, Naoko
    Uehara, Kano
    Kamada, Yoshihiko
    Tamaki, Nobumitsu
    Motonari, Tokiwa
    Unesoko, Mikiko
    Nakada, Norihiro
    Zaha, Hisamitsu
    Yoshimi, Naoki
    VIRCHOWS ARCHIV, 2020, 476 (05) : 701 - 709
  • [2] Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer
    Luque, Melani
    Sanz-Alvarez, Marta
    Morales-Gallego, Miriam
    Madoz-Gurpide, Juan
    Zazo, Sandra
    Dominguez, Carolina
    Cazorla, Alicia
    Izarzugaza, Yann
    Arranz, Juan Luis
    Cristobal, Ion
    Rojo, Federico
    CANCERS, 2022, 14 (24)
  • [3] Prognostic Implication of Tumor-Infiltrating Lymphocytes in Patients With HER2-Positive Breast Cancer
    Yoshida, E. J.
    Li, Q.
    Chung, A.
    Knudsen, B.
    Burnison, M.
    Mirhadi, A. J.
    Zumsteg, Z. S.
    Giuliano, A. E.
    Amersi, F. F.
    Shiao, S. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S44 - S45
  • [4] Investigating the role of tumor-infiltrating lymphocytes in advanced HER2-positive breast cancer
    Luen, Stephen J.
    Loi, Sherene
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (01)
  • [5] Prognostic value of tumor-infiltrating lymphocytes in small HER2-positive breast cancer
    Criscitiello, C.
    Bagnardi, V.
    Pruneri, G.
    Vingiani, A.
    Esposito, A.
    Rotmensz, N.
    Curigliano, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] HER2-Positive Breast Cancer: Association of MRI and Clinicopathologic Features With Tumor-Infiltrating Lymphocytes
    Lee, Hyo-Jae
    Lee, Jong Eun
    Jeong, Won Gi
    Ki, So Yeon
    Park, Min Ho
    Lee, Ji Shin
    Nah, Yoo Kyeong
    Lim, Hyo Soon
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2022, 218 (02) : 258 - 269
  • [7] Tumor-infiltrating lymphocytes and response prediction to neoadjuvant chemotherapy in HER2-positive breast cancer
    Heppner, B. Ingold
    Untch, M.
    Denkert, C.
    Pfitzner, B. M.
    Lederer, B.
    Schmidt, W.
    Eidtmann, H.
    Fasching, P.
    Tesch, H.
    Solbach, C.
    Rezai, M.
    Zahm, D. -M.
    Holms, F.
    Glados, M.
    Krabisch, P.
    Heck, E.
    Ober, A.
    Lorenz, P.
    Diebold, K.
    Habeck, J.
    Loibl, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 5 - 5
  • [8] Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade
    Liefaard, M. C.
    van der Voort, A.
    van Seijen, M.
    Thijssen, B.
    Sanders, J.
    Vonk, S.
    Mittempergher, L.
    Bhaskaran, R.
    de Munck, L.
    van Leeuwen-Stok, A. E.
    Salgado, R.
    Horlings, H. M.
    Lips, E. H.
    Sonke, G. S.
    NPJ BREAST CANCER, 2024, 10 (01)
  • [9] Tumor-infiltrating lymphocytes evaluation using machine learning image analysis based on core needle biopsy in HER2-positive breast cancer
    Abe, Norie
    Matsumoto, Hirofumi
    Takamatsu, Reika
    Tamaki, Kentaro
    Takigami, Naoko
    Uehara, Kanou
    Kamada, Yoshihiko
    Tamaki, Nobumitsu
    Motonari, Tokiwa
    Nakada, Norihiro
    Zaha, Hisamitsu
    Yoshimi, Naoki
    CANCER RESEARCH, 2020, 80 (04)
  • [10] Predicting the curative effects of TPD chemotherapy for HER2-positive breast cancer using tumor-infiltrating lymphocytes
    Kashiwagi, Shinichiro
    Goto, Wataru
    Asano, Yuka
    Takashima, Tsutomu
    Onoda, Naoyoshi
    Hirakawa, Kosei
    Ohira, Masaichi
    ANNALS OF ONCOLOGY, 2017, 28